Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16803 | 635 | 30.3 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
584 | 3 | POMPE DISEASE//PIN1//CYCLOPHILIN | 15652 |
1662 | 2 | POMPE DISEASE//GLYCOGEN STORAGE DISEASE//GLYCOGEN STORAGE DISEASE TYPE II | 6857 |
16803 | 1 | LAFORA DISEASE//POLYGLUCOSAN BODIES//LAFORIN | 635 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LAFORA DISEASE | authKW | 3923516 | 15% | 88% | 93 |
2 | POLYGLUCOSAN BODIES | authKW | 1796269 | 6% | 91% | 41 |
3 | LAFORIN | authKW | 1416336 | 6% | 82% | 36 |
4 | CORPORA AMYLACEA | authKW | 1185441 | 7% | 57% | 43 |
5 | ADULT POLYGLUCOSAN BODY DISEASE | authKW | 1017494 | 4% | 92% | 23 |
6 | LAFORA BODIES | authKW | 978358 | 4% | 88% | 23 |
7 | MALIN | authKW | 874286 | 3% | 91% | 20 |
8 | EPM2A | authKW | 772044 | 3% | 94% | 17 |
9 | POLYGLUCOSAN | authKW | 569432 | 2% | 79% | 15 |
10 | GLYCOGEN STORAGE DISEASE TYPE IV | authKW | 554397 | 2% | 82% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 5007 | 39% | 0% | 247 |
2 | Pathology | 3881 | 22% | 0% | 142 |
3 | Neurosciences | 1142 | 26% | 0% | 166 |
4 | Genetics & Heredity | 364 | 11% | 0% | 71 |
5 | Biochemistry & Molecular Biology | 192 | 18% | 0% | 117 |
6 | Pediatrics | 102 | 5% | 0% | 34 |
7 | Veterinary Sciences | 80 | 5% | 0% | 32 |
8 | Medicine, Research & Experimental | 57 | 5% | 0% | 30 |
9 | Cell Biology | 42 | 6% | 0% | 40 |
10 | Medical Laboratory Technology | 23 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSY GENET GENOM S | 171723 | 2% | 36% | 10 |
2 | BIOL SCI BIOENGN | 68893 | 4% | 6% | 23 |
3 | UO NEUROMUSCULAR NEURODEGENERAT DIS | 64113 | 0% | 67% | 2 |
4 | W LOS ANGELES DVA MED | 64113 | 0% | 67% | 2 |
5 | BEHAV NEUROLMOVEMENT DISORDER UNIT | 48086 | 0% | 100% | 1 |
6 | CALIFORNIA COMPREHENS EPILEPSY PROGRAM | 48086 | 0% | 100% | 1 |
7 | COMPREHANS EPILEPSY PROGRAM | 48086 | 0% | 100% | 1 |
8 | DIPARTIMENTO NEUROSCI RIABIL | 48086 | 0% | 100% | 1 |
9 | E PARIS NEUROMUSCULAR PATHOL REFERRAL | 48086 | 0% | 100% | 1 |
10 | ESTHER KOPLOVITZ | 48086 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA NEUROPATHOLOGICA | 13860 | 6% | 1% | 41 |
2 | CLINICAL NEUROPATHOLOGY | 4808 | 2% | 1% | 12 |
3 | HUMAN MOLECULAR GENETICS | 3051 | 4% | 0% | 25 |
4 | NEUROMUSCULAR DISORDERS | 2028 | 2% | 0% | 10 |
5 | JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 1836 | 2% | 0% | 11 |
6 | ANNALS OF NEUROLOGY | 1559 | 3% | 0% | 16 |
7 | EPILEPSIA | 1535 | 3% | 0% | 17 |
8 | LIVER | 1520 | 1% | 1% | 6 |
9 | NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY | 1269 | 1% | 0% | 7 |
10 | JOURNAL OF INHERITED METABOLIC DISEASE | 845 | 1% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LAFORA DISEASE | 3923516 | 15% | 88% | 93 | Search LAFORA+DISEASE | Search LAFORA+DISEASE |
2 | POLYGLUCOSAN BODIES | 1796269 | 6% | 91% | 41 | Search POLYGLUCOSAN+BODIES | Search POLYGLUCOSAN+BODIES |
3 | LAFORIN | 1416336 | 6% | 82% | 36 | Search LAFORIN | Search LAFORIN |
4 | CORPORA AMYLACEA | 1185441 | 7% | 57% | 43 | Search CORPORA+AMYLACEA | Search CORPORA+AMYLACEA |
5 | ADULT POLYGLUCOSAN BODY DISEASE | 1017494 | 4% | 92% | 23 | Search ADULT+POLYGLUCOSAN+BODY+DISEASE | Search ADULT+POLYGLUCOSAN+BODY+DISEASE |
6 | LAFORA BODIES | 978358 | 4% | 88% | 23 | Search LAFORA+BODIES | Search LAFORA+BODIES |
7 | MALIN | 874286 | 3% | 91% | 20 | Search MALIN | Search MALIN |
8 | EPM2A | 772044 | 3% | 94% | 17 | Search EPM2A | Search EPM2A |
9 | POLYGLUCOSAN | 569432 | 2% | 79% | 15 | Search POLYGLUCOSAN | Search POLYGLUCOSAN |
10 | GLYCOGEN STORAGE DISEASE TYPE IV | 554397 | 2% | 82% | 14 | Search GLYCOGEN+STORAGE+DISEASE+TYPE+IV | Search GLYCOGEN+STORAGE+DISEASE+TYPE+IV |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MONAGHAN, TS , DELANTY, N , (2010) LAFORA DISEASE EPIDEMIOLOGY, PATHOPHYSIOLOGY AND MANAGEMENT.CNS DRUGS. VOL. 24. ISSUE 7. P. 549 -561 | 85 | 83% | 13 |
2 | GENTRY, MS , ROMA-MATEO, C , SANZ, P , (2013) LAFORIN, A PROTEIN WITH MANY FACES: GLUCAN PHOSPHATASE, ADAPTER PROTEIN, ET ALII.FEBS JOURNAL. VOL. 280. ISSUE 2. P. 525 -537 | 58 | 71% | 14 |
3 | CAVANAGH, JB , (1999) CORPORA-AMYLACEA AND THE FAMILY OF POLYGLUCOSAN DISEASES.BRAIN RESEARCH REVIEWS. VOL. 29. ISSUE 2-3. P. 265 -295 | 81 | 67% | 135 |
4 | SINGH, S , GANESH, S , (2009) LAFORA PROGRESSIVE MYOCLONUS EPILEPSY: A META-ANALYSIS OF REPORTED MUTATIONS IN THE FIRST DECADE FOLLOWING THE DISCOVERY OF THE EPM2A AND NHLRC1 GENES.HUMAN MUTATION. VOL. 30. ISSUE 5. P. 715-723 | 46 | 94% | 34 |
5 | ROMA-MATEO, C , SANZ, P , GENTRY, MS , (2012) DECIPHERING THE ROLE OF MALIN IN THE LAFORA PROGRESSIVE MYOCLONUS EPILEPSY.IUBMB LIFE. VOL. 64. ISSUE 10. P. 801-808 | 43 | 86% | 4 |
6 | GAYARRE, J , DURAN-TRIO, L , GARCIA, OC , AGUADO, C , JUANA-LOPEZ, L , CRESPO, I , KNECHT, E , BOVOLENTA, P , DE CORDOBA, SR , (2014) THE PHOSPHATASE ACTIVITY OF LAFORIN IS DISPENSABLE TO RESCUE EPM2A(-/-) MICE FROM LAFORA DISEASE.BRAIN. VOL. 137. ISSUE . P. 806-818 | 40 | 85% | 4 |
7 | SINGH, S , GANESH, S , (2012) PHENOTYPE VARIATIONS IN LAFORA PROGRESSIVE MYOCLONUS EPILEPSY: POSSIBLE INVOLVEMENT OF GENETIC MODIFIERS?.JOURNAL OF HUMAN GENETICS. VOL. 57. ISSUE 5. P. 283-285 | 39 | 93% | 1 |
8 | ZENG, L , WANG, Y , BABA, O , ZHENG, P , LIU, Y , LIU, Y , (2012) LAFORIN IS REQUIRED FOR THE FUNCTIONAL ACTIVATION OF MALIN IN ENDOPLASMIC RETICULUM STRESS RESISTANCE IN NEURONAL CELLS.FEBS JOURNAL. VOL. 279. ISSUE 14. P. 2467-2478 | 40 | 87% | 8 |
9 | AKMAN, HO , EMMANUELE, V , KURT, YG , KURT, B , SHEIKO, T , DIMAURO, S , CRAIGEN, WJ , (2015) A NOVEL MOUSE MODEL THAT RECAPITULATES ADULT-ONSET GLYCOGENOSIS TYPE 4.HUMAN MOLECULAR GENETICS. VOL. 24. ISSUE 23. P. 6801 -6810 | 31 | 89% | 0 |
10 | ROMA-MATEO, C , AGUADO, C , GARCIA-GIMENEZ, JL , KNECHT, E , SANZ, P , PALLARDO, FV , (2015) OXIDATIVE STRESS, A NEW HALLMARK IN THE PATHOPHYSIOLOGY OF LAFORA PROGRESSIVE MYOCLONUS EPILEPSY.FREE RADICAL BIOLOGY AND MEDICINE. VOL. 88. ISSUE . P. 30 -41 | 54 | 49% | 1 |
Classes with closest relation at Level 1 |